Clinical Trials Logo

Clinical Trial Summary

To improve accuracy and take out human error opportunities, Hippo Dx developed S.P.A.T., an automated skin prick test. This study will provide a comparison between manual and automated skin prick test in allergic and non-allergic individuals with a panel of common inhalant allergens. The primary endpoint is to compare the accuracy of S.P.A.T. to detect sensitization to common aeroallergens compared to a manual skin prick test (SPT). It is a prospective monocentric study that will include 120 study participants.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05824637
Study type Interventional
Source Hippocreates
Contact
Status Completed
Phase N/A
Start date March 18, 2023
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT03315611 - Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis N/A
Completed NCT05301647 - Mometasone Furoate Nasal Spray in Italian Children
Completed NCT03816800 - Iron and Pollen Allergy in Women N/A
Not yet recruiting NCT05533385 - Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation. N/A
Not yet recruiting NCT05532566 - Quercus Ilex and Quercus Robur Allergen Extracts Standardisation N/A
Not yet recruiting NCT06167564 - Allergy Diagnostic Test Based on Microchip Technology N/A
Recruiting NCT03514303 - Microassay and Allergy Skin Prick Test Correlation Study